Drugs@FDA document
ABILIFY MAINTENA KIT Letter · NDA 202971 SUPPL-18
Drugs@FDA document · OTSUKA PHARM CO LTD · Apr 9, 2025
Key facts
| Drug name | ABILIFY MAINTENA KIT |
|---|---|
| Document type | Letter |
| Application | NDA202971 |
| Submission | SUPPL-18 |
| Company | OTSUKA PHARM CO LTD |
| Document date | Apr 9, 2025 |
At a glance
- Efficacy-New Dosing Regimen Document categories
- 10–99 Documents for this application
- 1–9 USP chapters cited in this application's documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA documents
Drugs@FDA posts the letters, labels, reviews and other documents behind each drug application and supplement. Orca1 indexes every document's full text and flags complete response letters.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA application documents · Source date: